| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01Q30-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01Q20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01Q30-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01Q60-366 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01Q30-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01Q60-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01Q20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01Q30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y35-00 |
| filingDate |
2014-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd624e5cbcb4ec4153663e95e241fb82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6f111ea543f50a5f2f9024b3d24061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac816a2e466592a10dbe269c992b95c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11d1e132ec9e428eccbe9cba9e581cac |
| publicationDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9678105-B2 |
| titleOfInvention |
Analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring |
| abstract |
Described herein is the analysis of nanomechanical characteristics of cells. In particular, changes in certain local nanomechanical characteristics of ex vivo human cells can correlate with presence of a human disease, such as cancer, as well as a particular stage of progression of the disease. Also, for human patients that are administered with a therapeutic agent, changes in local nanomechanical characteristics of ex vivo cells collected from the patients can correlate with effectiveness of the therapeutic agent in terms of impeding or reversing progression of the disease. By exploiting this correlation, systems and related methods can be advantageously implemented for disease state detection and therapeutic agent selection and monitoring. |
| priorityDate |
2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |